Peter F. Smith
Alnylam Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Carcinogens and Genotoxicity Assessment, Drug-Induced Hepatotoxicity and Protection, Computational Drug Discovery Methods, Liver physiology and pathology, Drug Transport and Resistance Mechanisms
Most-Cited Works
- → Mouse Cristin/R-spondin Family Proteins Are Novel Ligands for the Frizzled 8 and LRP6 Receptors and Activate β-Catenin-dependent Gene Expression(2006)282 cited
- → Mineral Analysis of Plant Tissues(1962)246 cited
- → Safety Evaluation of Lipid Nanoparticle–Formulated Modified mRNA in the Sprague-Dawley Rat and Cynomolgus Monkey(2017)184 cited
- → HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.(1991)147 cited
- → Dynamic organ culture of precision liver slices for toxicology(1985)139 cited
- → The Effects of Overfeeding and Dietary Restriction on Sprague-Dawley Rat Survival and Early Pathology Biomarkers of Aging(1994)126 cited
- → Maintenance of adult rat liver slices in dynamic organ culture(1986)105 cited
- → Diet, Overfeeding, and Moderate Dietary Restriction in Control Sprague-Dawley Rats: I. Effects on Spontaneous Neoplasms(1995)98 cited
- → Diet, Overfeeding, and Moderate Dietary Restriction in Control Sprague-Dawley Rats: II. Effects on Age-Related Proliferative and Degenerative Lesions(1995)95 cited
- → Safety evaluation of 2′-deoxy-2′-fluoro nucleotides in GalNAc-siRNA conjugates(2019)77 cited